Artio Medical, Inc., a Fairway, Kan.-based medical device company developing innovative products for the peripheral vascular and neurovascular markets, closed an additional $8.8m in Series A financing.
This round brought the total capital raised to date to more than $20m.
The company intends to use the funds to obtain 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA) to market the Solus Gold™ Embolization Device in the US.
Led by F. Nicholas Franano, MD, President and CEO, Artio is a medical device company committed to developing innovative endovascular products for the treatment of peripheral vascular, neurovascular, and structural heart diseases. Its products are designed to provide precision placement, immediate occlusion, and rapid sealing of arteries, veins, saccular aneurysms, and other blood-containing structures.